Elekta is a leading human care company, specialising in cancer and brain disorders treatment. Based in Stockholm, Sweden, Elekta offers advanced equipment and software to more than 6,000 hospitals worldwide. The company’s products are divided into the Elekta Neuroscience, Elekta Oncology, Elekta Brachytherapy, and Elekta Software lines. The company has a long history of acquisitions, including deals with Philips Medical Systems, Finland’s Neuromag, IMPAC Medical Systems, CMS, Canada’s Resonant Medical, and Nucletron. Elekta trades on the NASDAQ Stockholm under the EKTA B ticker. Stay tuned to the latest Elekta share price swings with Capital.com.